S. F. Anthony, and H. L. Clifford. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In: E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, and J. L. Jameson (eds.), Harrison’s Principles of Internal Medicine, McGraw-Hill, New York, USA, 2001, pp. 1852–1913.
O. L. Laskin, P. de Miranda, and M. R. Blum. Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex. J. Infect. Dis
159 (no. 4): 745–747 (1989).
S. Chitnis, D. Mondal, and K. C. Agrawal. Zidovudine (AZT) treatment suppresses granulocyte–monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells. Life Sci
P. Chariot, I. Drogou, I. de Lacroix-Szmania, M. C. Eliezer-Vanerot, B. Chazaud, A. Lombes, A. Schaeffer, and E. S. Zafrani. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J. Hepatol
(no. 1): 156–160 (1999).CrossRef
M. C. Re, I. Bon, P. Monari, R. Gorini, P. Schiavone, D. Gibellini, and M. La Placa. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance. New Microbiol
26 (no. 4): 405–413 (2003).
Y. W. Chien. Novel drug delivery systems. In Y. W. Chien (ed.), Oral Drug Delivery and Delivery Systems, Marcel Dekker, New York, USA, 1992, pp. 139–196.
S. P. Vyas, and R. K. Khar. Controlled drug delivery: Concepts and advances. In S. P. Vyas, and R. K. Khar (eds.), Controlled oral administration, Vallabh Prakashan, Delhi, India, 2002, pp. 155–195.
R. K. V. Ranga, D. K. Padmalatha, and B. Buri. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm
I. Zabeed, B. Almas, and A. Muhammad. Controlled release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method. Drug Dev. Ind. Pharm
(no. 2):129–134 (2002).CrossRef
M. Riikka, S. Eero, K. Ossi, P. Heli, N. Riku, L. Marko, and K. Jarkko. Controlled release of saccharides from matrix tablets. Eur. J. Pharm. Biopharm
A. B. Silvina, C. L. Marcia, and J. S. Claudio. Swellable matrices for the controlled-release of diclofenac sodium. Formulation and in vitro
studies. Pharm. Dev. Tech
(no. 1): 75–83 (2004).CrossRef
T. A. Manuel, and V. R. Leopoldo. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev. Ind. Pharm
(no. 8): 901–908 (2004).CrossRef
R. W. Korsenmeyer, and N. A. Peppas. Macromolecular and modeling aspects of swelling-controlled systems. In S. Z. Mansdorf, and T. J. Roseman (eds.), Controlled Release Delivery Systems, Marcel Dekker, New York, USA, 1983, p. 77.
B. J. Lee, S. G. Ryu, and J. H. Cui. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev. Ind. Pharm
C. L. Vargas, and E. S. Ghaly. Kinetic release of theophylline from hydrophilic swellable matrices. Drug Dev. Ind. Pharm
M. V. Velasco, J. L. Ford, P. Rowe, and A. R. Rajabi-Siahboomi. Influence of drug:hydroxypropyl methylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC matrices. J. Control. Rel
C. Sajeev, and R. N. Saha. Formulation and comparative evaluation of controlled release diclofenac tablets prepared by matrix embedding technique, membrane barrier technique and combination of the two. Drug Dev. Res
(no. 1): 1–8 (2001).CrossRef
P. Jelena, D. Zorica, J. Milica, and I. Svetlana. An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Delivery
G. S. Rekhi, and S. S. Jambhekar. Ethyl cellulose—a polymer review. Drug Dev. Ind. Pharm
P. R. Katikaneni, S. M. Upadrashta, S. H. Neau, and A. K. Mitra. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int. J. Pharm
S. H. Neau, M. A. Howard, J. S. Claudius, and D. R. Howard. The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets. Int. J. Pharm
K. Atul, K. T. Ashok, K. J. Narendra, and J. Subheet. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm. Sci. Tech.
7(1) (2006) (article 1).
H. A. Benghuzzi, R. M. Barbaro, and P. K. Bajpai. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems. Biomed. Sci. Instrum
H. A. Benghuzzi. Long-term sustained delivery of 3’-azido-2’,3’-dideoxythymidine in vivo by means of HA and TCP delivery devices. Biomed. Sci. Instrum
R. R. Punna, and R. N. Saha. A new rapid, simple and validated UV spectrophotometric method for estimation of zidovudine in bulk, formulations and dissolution samples. AAPS J. 6(4) (2004) (Abstract T3054).
S. Li, Y. Shen, W. Li, and X. Hao. A common profile for polymer-based controlled release and its logical interpretation to general release process. J. Pharm. Pharmaceut. Sci
R. L. Ritger, and N. A. Peppas. A simple equation for the description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Rel
P. Costa, and J. M. S. Lobo. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci
A. A. S. Araujo, S. Stropirtis, L. P. Mercuri, F. M. S. Carvalho, F. M. dos Santos, and J. R. Matos. Thermal analysis of the antiretroviral Zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int. J. Pharm
J. L. Ford, M. H. Rubunstein, and J. E. Hogan. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropyl methylcellulose. Int. J. Pharm
M. A. Anjali, H. N. Steven, and L. B. Peter. Wet granulation fine particle ethyl cellulose tablets: Effect of production variables and mathematical modeling of drug release. AAPS PharmSci. 5(2):article 13 (2003).
H. Kim, and R. Fassihi. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci
(no. 3): 323–328 (1997).CrossRef
B. P. Marcos, J. L. Ford, D. J. Armstrong, P. N. C. Elliott, C. Rostron, and J. E. Hogan. Influence of pH on the release of propranolol hydrochloride from matrices containing HPMC K4 M and Carbopol 974. J. Pharm. Sci
(no. 3): 330–334 (1996).CrossRef
F. Atsuko, F. Ryuta, Y. Yorinobu, and S. Hisakazu. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules III.1) Effects of the dissolution condition on the release process. Chem. Pharm. Bull
(no. 8): 1091–1096 (2006).CrossRef
N. R. Maichel, L. S. Roger, and B. S. Joseph. The effect of formulation composition and dissolution parameters on the gel strength of controlled release hydrogel tablets. Pharm. Dev. Tech
(no. 4): 583–593 (2001).CrossRef